Sarepta Therapeutics,, Inc. Common Stock Share Price
NASDAQ: SRPTHealthcare
Live Sarepta Therapeutics,, Inc. Common Stock Share Price Chart
O H L
Sarepta Therapeutics,, Inc. Common Stock Performance Overview
Days Range
▼
$19.84Low
$20.66High
Markets Today
| Previous Close | $20.67 |
|---|---|
| Open | $20.66 |
| Volume | 427,673 |
| Day's Range | $19.84 - $20.66 |
| 52W Range | $14.68 - $25.32 |
| Market Cap | $2.09 B |
Historical Performance
| 1M Returns | +14.71 |
|---|---|
| 3M Returns | +17.91 |
| 6M Returns | +20.45 |
| 1Y Returns | +11.61 |
| 5Y Returns | -76.07 |
| 10Y Returns | -57.76 |
Sarepta Therapeutics,, Inc. Common Stock Fundamentals
| Market Cap | $2.09 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $2.20 B |
| ROE TTM | -0.53 |
| EPS TTM | $-1.66 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.37 |
| EBITDA | $-613.25 M |
| Profit Margin | -32.45 |
| Market Cap | $2.09 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $2.20 B |
| ROE TTM | -0.53 |
| EPS TTM | $-1.66 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.37 |
| EBITDA | $-613.25 M |
| Profit Margin | -32.45 |
Sarepta Therapeutics,, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $744.86 M | $611.09 M | $399.36 M | $442.93 M | $730.80 M | $401.25 M |
| Gross Profit + | $607.29 M | $458.53 M | $248.58 M | $44.23 M | $622.03 M | $251.87 M |
| Operating Income | -$300.39 M | $115.58 M | -$103.39 M | -$411.58 M | $358.43 M | $13.29 M |
| EBITDA | -$290.41 M | $126.42 M | -$44.43 M | -$404.83 M | $369.03 M | $62.70 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $9.98 M | $10.84 M | $58.96 M | $6.75 M | $10.59 M | $49.41 M |
| Income Before Tax | -$383.52 M | $153.64 M | -$194.05 M | -$278.30 M | $343.17 M | -$1.75 M |
| Income Tax Expense | $63.99 M | -$43.25 M | -$14.10 M | $4.55 M | $12.21 M | $3.14 M |
| Net Income + | -$447.51 M | $196.89 M | -$179.95 M | -$282.85 M | $330.96 M | -$4.89 M |
| Net Profit Margin | -60.08% | 32.22% | -45.06% | -63.86% | 45.29% | -1.22% |
Sarepta Therapeutics,, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $10.00 K | $10.00 K | $11.00 K | $11.00 K | $11.00 K | $11.00 K |
| Reserve & Surplus | -$4.66 B | -$4.46 B | -$4.64 B | -$4.88 B | -$4.55 B | -$4.55 B |
| Non-Current Liabilities | $1.72 B | $1.40 B | $1.25 B | $1.11 B | $1.17 B | $1.16 B |
| Current Liabilities | $605.59 M | $919.95 M | $921.42 M | $1.10 B | $499.16 M | $502.91 M |
| Total Liabilities | $2.32 B | $2.32 B | $2.17 B | $2.21 B | $1.67 B | $1.66 B |
| Fixed Assets | $360.59 M | $371.86 M | $358.94 M | $345.13 M | $336.24 M | $325.99 M |
| Current Assets | $2.43 B | $2.66 B | $2.72 B | $2.54 B | $2.31 B | $2.22 B |
| Total Assets | $3.47 B | $3.68 B | $3.49 B | $3.35 B | $3.18 B | $3.19 B |
Sarepta Therapeutics,, Inc. Common Stock Cash Flow
Quarterly
| Dec 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$282.85 M | -$282.85 M | $330.96 M | $330.96 M | -$4.89 M | -$4.89 M |
| Operating Cash Flow | $131.21 M | $131.21 M | -$202.68 M | -$202.68 M | $197.07 M | $197.07 M |
| Investing Cash Flow | $96.21 M | $96.21 M | -$134.39 M | -$134.39 M | -$93.37 M | -$93.37 M |
| Financing Cash Flow | -$39.21 M | -$39.21 M | $241.00 K | $241.00 K | $0 | $0 |
| Change in Cash | $188.21 M | $188.21 M | -$336.83 M | -$336.83 M | $103.70 M | $103.70 M |
Sarepta Therapeutics,, Inc. Common Stock Return Calculator
The Sarepta Therapeutics,, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$2,327
Invested Amount$10,000
Est. Returns$-7,673
About Sarepta Therapeutics,, Inc. Common Stock
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
Popular Stocks
FAQs
What is the share price of Sarepta Therapeutics,, Inc. Common Stock today?
Sarepta Therapeutics,, Inc. Common Stock (SRPT) share price as of September 18, 2026 is $20.10. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Sarepta Therapeutics,, Inc. Common Stock?
Yes, Indian Investors can invest in the Sarepta Therapeutics,, Inc. Common Stock (SRPT) Share by opening an international trading account with Angel One.
How can I purchase Sarepta Therapeutics,, Inc. Common Stock shares in India?
Purchasing Sarepta Therapeutics,, Inc. Common Stock (SRPT) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Sarepta Therapeutics,, Inc. Common Stock (SRPT) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Sarepta Therapeutics,, Inc. Common Stock?
Yes, you can purchase fractional shares of Sarepta Therapeutics,, Inc. Common Stock (SRPT) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Sarepta Therapeutics,, Inc. Common Stock?
The market capitalization of Sarepta Therapeutics,, Inc. Common Stock on September 18, 2026, is $2.09 B.
In which sector Sarepta Therapeutics,, Inc. Common Stock belongs?
Sarepta Therapeutics,, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Sarepta Therapeutics,, Inc. Common Stock stocks?
In order to invest in Sarepta Therapeutics,, Inc. Common Stock (SRPT) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
